| Bacteremia associated with tunneled dialysis catheters: comparison of two treatment strategies B Tanriover, D Carlton, S Saddekni, K Hamrick, R Oser, AO Westfall, ... Kidney international 57 (5), 2151-2155, 2000 | 385 | 2000 |
| Donor-specific antibodies adversely affect kidney allograft outcomes S Mohan, A Palanisamy, D Tsapepas, B Tanriover, RJ Crew, G Dube, ... Journal of the American Society of Nephrology 23 (12), 2061-2071, 2012 | 314 | 2012 |
| Reduced fracture risk with early corticosteroid withdrawal after kidney transplant LE Nikkel, S Mohan, A Zhang, DJ McMahon, S Boutroy, G Dube, ... American Journal of Transplantation 12 (3), 649-659, 2012 | 151 | 2012 |
| Kidneys at higher risk of discard: expanding the role of dual kidney transplantation B Tanriover, S Mohan, DJ Cohen, J Radhakrishnan, TL Nickolas, ... American Journal of Transplantation 14 (2), 404-415, 2014 | 129 | 2014 |
| Improvement in 3-month patient-reported gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients P Bolin, B Tanriover, GB Zibari, ML Lynn, JD Pirsch, L Chan, M Cooper, ... Transplantation 84 (11), 1443-1451, 2007 | 82 | 2007 |
| Screening asymptomatic diabetic patients for coronary artery disease prior to renal transplantation V Ramanathan, S Goral, B Tanriover, ID Feurer, R Kazancioglu, D Shaffer, ... Transplantation 79 (10), 1453-1458, 2005 | 78 | 2005 |
| Induction therapies in live donor kidney transplantation on tacrolimus and mycophenolate with or without steroid maintenance B Tanriover, S Zhang, M MacConmara, A Gao, B Sandikci, MUS Ayvaci, ... Clinical Journal of the American Society of Nephrology 10 (6), 1041-1049, 2015 | 74 | 2015 |
| Acute rejection rates and graft outcomes according to induction regimen among recipients of kidneys from deceased donors treated with tacrolimus and mycophenolate B Tanriover, V Jaikaransingh, MP MacConmara, JR Parekh, SL Levea, ... Clinical Journal of the American Society of Nephrology 11 (9), 1650-1661, 2016 | 65 | 2016 |
| Polyclonal antibody-induced serum sickness in renal transplant recipients: treatment with therapeutic plasma exchange B Tanriover, P Chuang, B Fishbach, JH Helderman, T Kizilisik, ... Transplantation 80 (2), 279-281, 2005 | 57 | 2005 |
| Making every liver count: increased transplant yield of donor livers through normothermic machine perfusion M MacConmara, SI Hanish, CS Hwang, L De Gregorio, DM Desai, ... Annals of surgery 272 (3), 397-401, 2020 | 55 | 2020 |
| Characteristics and performance of unilateral kidney transplants from deceased donors SA Husain, MC Chiles, S Lee, SO Pastan, RE Patzer, B Tanriover, ... Clinical Journal of the American Society of Nephrology 13 (1), 118-127, 2018 | 49 | 2018 |
| Analysis of kidney function and biopsy results in liver failure patients with renal dysfunction: a new look to combined liver kidney allocation in the post-MELD era B Tanriover, A Mejia, J Weinstein, SV Foster, R Ghalib, A Mubarak, ... Transplantation 86 (11), 1548-1553, 2008 | 48 | 2008 |
| Availability, utilization and outcomes of deceased diabetic donor kidneys; analysis based on the UNOS registry S Mohan, B Tanriover, N Ali, RJ Crew, GK Dube, J Radhakrishnan, ... American Journal of Transplantation 12 (8), 2098-2105, 2012 | 42 | 2012 |
| Future of Medicare immunosuppressive drug coverage for kidney transplant recipients in the United States B Tanriover, PW Stone, S Mohan, DJ Cohen, RS Gaston Clinical Journal of the American Society of Nephrology 8 (7), 1258-1266, 2013 | 40 | 2013 |
| Short-term outcomes of deceased donor renal transplants of HCV uninfected recipients from HCV seropositive nonviremic donors and viremic donors in the era of direct-acting … RM La Hoz, B Sandıkçı, VK Ariyamuthu, B Tanriover American Journal of Transplantation 19 (11), 3058-3070, 2019 | 37 | 2019 |
| Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation DS Tsapepas, R Vasilescu, B Tanriover, Y Coppleson, Y Rekhtman, ... Transplantation 97 (6), 642-647, 2014 | 37 | 2014 |
| High-dose intravenous immunoglobulin and rituximab treatment for antibody-mediated rejection after kidney transplantation: a cost analysis B Tanriover, SE Wright, SV Foster, KS Roush, JA Castillo-Lugo, K Fa, ... Transplantation proceedings 40 (10), 3393-3396, 2008 | 35 | 2008 |
| The prevention of COVID-19 in high-risk patients using tixagevimab–cilgavimab (Evusheld): Real-world experience at a large academic center MM Al-Obaidi, AB Gungor, SE Kurtin, AE Mathias, B Tanriover, ... The American journal of medicine 136 (1), 96-99, 2023 | 34 | 2023 |
| Cost-effectiveness of antibody-based induction therapy in deceased donor kidney transplantation in the United States Z Gharibi, MUS Ayvaci, M Hahsler, T Giacoma, RS Gaston, B Tanriover Transplantation 101 (6), 1234-1241, 2017 | 33 | 2017 |
| Characteristics and outcomes among patients with need for early dialysis after lung transplantation surgery A Banga, M Mohanka, J Mullins, S Bollineni, V Kaza, B Tanriover, ... Clinical Transplantation 31 (11), e13106, 2017 | 31 | 2017 |
